CMET-30. LEPTOMENINGEAL METASTASES: OUTCOMES WITH AGGRESSIVE MULTIMODALITY TREATMENT

INTRODUCTION: Leptomeningeal metastases (LM) affect 5–8% of cancer patients; median survivals historically have ranged from 12–16 weeks. Earlier intervention, multimodal treatment, intrathecal chemotherapy, and targeting relevant molecular drivers may improve outcomes. METHODS: Under an IRB-approved...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neuro Oncol
Autori principali: Smith, Rachel, Boman, Christina, Thatikonda, Srivani, Dziuk, Timothy, Tumu, Hari, Hellerstedt, Beth, Patt, Debra, Nuesch, Carl, Pearson, Rachel, Cohen, Karen, Kemper, Craig, Sheinbein, Courtney, Kim, Stanley, Fain, Jerry, de Celis, Carlos Rubin, Melear, Jason, Groves, Morris D
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2017
Soggetti:
Abstracts
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692985/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.177
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi